Johns Hopkins University, $20,000

Gastric bypass surgery leads to the remission of type II diabetes in up to 98% of patients, but it is invasive. By using key insights from surgery, this team is developing a less invasive method that modulates the GI tract and leads to improvements in blood glucose control and reduces long term complications of the disease.

By continuing to use the site, you agree to the use of cookies. Read More